# Enlivex Therapeutics Ltd. (ENLV)

> Healthcare · IL · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/ENLV/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 0 | $ 1.27B | $ -11.36M | $ 641.0K | $ 1.93B |
| 2024 | $ 0 | $ -15.78M | $ -13.78M | $ 534.0K | $ 23.59M |
| 2023 | $ 0 | $ -31.43M | $ -25.42M | N/A | $ 30.08M |
| 2022 | $ 0 | $ -34.70M | $ -35.83M | $ 4.85M | $ 56.84M |
| 2021 | $ 0 | $ -17.20M | $ -22.78M | $ 6.01M | $ 85.04M |
| 2020 | $ 0 | $ -15.06M | $ -15.32M | $ 203.0K | $ 35.49M |
| 2019 | $ 0 | $ -12.11M | $ -9.34M | $ 123.0K | $ 11.28M |
| 2018 | $ 0 | $ -5.60M | $ -4.78M | $ 0 | $ 9.71M |
| 2017 | $ 0 | $ -8.01M | $ -8.56M | $ 0 | $ 3.16M |
| 2016 | $ 0 | $ -22.04M | $ -21.33M | $ 0 | $ 8.70M |
| 2015 | $ 0 | $ -21.57M | $ -18.67M | $ 0 | $ 17.93M |
| 2014 | $ 0 | $ -9.92M | $ -6.32M | $ 0 | $ 30.67M |
| 2013 | $ 0 | $ -1.90M | $ -1.17M | $ 0 | $ 5.56M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | 0.20 |
| Current Ratio | 193.24 |

## Debt coverage

| Indicator | Value |
| --- | --- |
| Gross Debt / Earnings | 0.01 |

## Other views

- [Metrics](https://sponda.capital/en/ENLV.md)
- [Charts](https://sponda.capital/en/ENLV/charts.md)
- [Compare](https://sponda.capital/en/ENLV/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.